Hoag Memorial Hospital Presbyterian
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Hoag Memorial Hospital Presbyterian sits in the top decile of US sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count).
Hoag Memorial Hospital Presbyterian: 20 sponsored US clinical trials, 3 recruiting.
Hoag Memorial Hospital Presbyterian sponsors 20 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 15 completed. 0 of these trials are in Phase 3-4 (later-stage) and 12 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 2 trials.
Top-decile sponsor footprint
Hoag Memorial Hospital Presbyterian ranks in the top decile of sponsors by registered trial count (#743 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
15 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
20 total, page 1 of 1
A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
NCT06736054
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
NCT04700332
Perioperative Mindfulness Proposal
NCT04049214
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
NCT03889119
A Phase 2 Trial of 61Cu-NU101 PET/CT Compared Against Current Standard-of-care 18F-piflufolastat (Pylarify®) PET/CT.
NCT07635524
PET MRI as a Staging Tool for Head and Neck Cancer
NCT04750434
Transition to Adult Care in Type 1 Diabetes
NCT03886974
Coaching for Cognition in Alzheimer's (COCOA)
NCT03424200
Evaluating Outcomes for Ethnically Diverse Patients With Type 2 Diabetes Participating in a Diabetes Education Program
NCT03464812
Pancreatic Cancer Early Detection Registry
NCT05519930
Intraoperative Radiotherapy for Early Stage Breast Cancer
NCT01189851
Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma
NCT00436930
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
NCT00049413
Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells
NCT00948480
Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme
NCT00331526
High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
NCT00003091
Biological Therapy in Treating Patients With Metastatic Cancer
NCT00002733
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
NCT00002504
Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
NCT00002506
Tumor Cell Vaccine in Treating Patients With Advanced Cancer
NCT00002505
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 11 |
Therapeutic Areas
What is open in the Hoag Memorial Hospital Presbyterian pipeline
3 recruiting of 20 indexed (15% open); 15 completed (75%).
Phase mix: 0 late (III/IV) vs 12 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (2 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Hoag Memorial Hospital Presbyterian: open-pipeline peers nationwide
Peers matched on 20 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Hoag Memorial Hospital Presbyterian sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 20 trials (± recruiting share)
- 59th Medical Wing · 20 trials · 15% recruiting
- Abiomed · 20 trials · 10% recruiting
- Agency for Healthcare Research and Quality (AHRQ) · 20 trials · 0% recruiting
- Alliance Foundation Trials · 20 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Medtronic Neurovascular Clinical Affairs · 15% recruiting · 20 trials
- Vivek Reddy · 15% recruiting · 20 trials
- Georgetown University · 15% recruiting · 227 trials
- Arizona State University · 15% recruiting · 187 trials
Related
What to do with this Hoag Memorial Hospital Presbyterian page
20 registered trials is a research-attention snapshot, not an endorsement of Hoag Memorial Hospital Presbyterian or any single study.
- 3 of Hoag Memorial Hospital Presbyterian's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Hoag Memorial Hospital Presbyterian studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Hoag Memorial Hospital Presbyterian pipeline card: 20 registered trials from official public datasets.Report a data error.